A previous report showed that knockdown of VSIG4 in human pancreatic cancer cells attenuated tumor growth and metastasis in vivo, while the immune microenvironment was missed due to the disadvantage of the nude mouse xenograft model [50]. This evidence concerns the gene VSIG4 and pancreatic neoplasm.